Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methods for improved hemorrhage control.

John B Holcomb1

  • 1Trauma Division, US Army Institute of Surgical Research, Fort Sam Houston, Texas, USA. John.Holcomb@cen.amedd.army.mil

Critical Care (London, England)
|June 16, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Abnormalities of laboratory coagulation tests versus clinically evident coagulopathic bleeding: results from the prehospital resuscitation on helicopters study (PROHS).

Surgery·2018
Same author

Contemporary Utilization of Resuscitative Thoracotomy: Results From the AAST Aortic Occlusion for Resuscitation in Trauma and Acute Care Surgery (AORTA) Multicenter Registry.

Shock (Augusta, Ga.)·2017
Same author

The effects of cryopreserved red blood cell transfusion on tissue oxygenation in obese trauma patients.

The journal of trauma and acute care surgery·2017
Same author

Mesenchymal stem cell-derived extracellular vesicles attenuate pulmonary vascular permeability and lung injury induced by hemorrhagic shock and trauma.

The journal of trauma and acute care surgery·2017
Same author

Risk Factors for the Development of Acute Respiratory Distress Syndrome Following Hemorrhage.

Shock (Augusta, Ga.)·2017
Same author

The trauma center is too late: Major limb trauma without a pre-hospital tourniquet has increased death from hemorrhagic shock.

The journal of trauma and acute care surgery·2017
Same journal

45th International Symposium on Intensive Care & Emergency Medicine.

Critical care (London, England)·2026
Same journal

High-resolution monitoring reveals fragmented 24-hour light exposure in intensive care units.

Critical care (London, England)·2026
Same journal

Coronary microvascular function in patients with sepsis and myocardial injury: an invasive coronary physiology study.

Critical care (London, England)·2026
Same journal

Comparative performance of mitral E/e' versus inferior vena cava variability for predicting fluid responsiveness in mechanically ventilated adults with shock.

Critical care (London, England)·2026
Same journal

Different lungs or different patients? Insights into postoperative ARDS.

Critical care (London, England)·2026
Same journal

Predictive validity of SOFA-2: analytical and contextual considerations.

Critical care (London, England)·2026
See all related articles

New drugs, including injectable hemostatics, fibrin foams, and dressings, show promise for controlling life-threatening hemorrhage in trauma patients. Further human studies are needed to confirm their effectiveness in reducing trauma mortality.

Area of Science:

  • Trauma care
  • Hemorrhage control
  • Pharmacological interventions

Background:

  • Trauma is a leading cause of death in the USA, particularly among young adults.
  • Uncontrolled hemorrhage is a major contributor to preventable trauma deaths.
  • Advancements in hemorrhage control are critical for reducing trauma mortality.

Purpose of the Study:

  • To review new drugs for managing life-threatening hemorrhage in trauma patients.
  • To highlight the potential of novel hemostatic agents.

Main Methods:

  • Review of current literature on drugs for hemorrhage control in trauma.
  • Focus on injectable hemostatics, fibrin foams, and dressings.
  • Evaluation of animal and human study data.

Related Experiment Videos

Main Results:

  • New drug formulations like injectable hemostatics, fibrin foams, and dressings are emerging.
  • Animal studies demonstrate encouraging results for these agents.
  • Human studies are currently lacking but deemed necessary.

Conclusions:

  • Novel hemostatic drugs offer potential for improved hemorrhage control in trauma.
  • Further clinical trials are required to validate efficacy and safety in human patients.
  • These advancements could significantly impact trauma mortality rates.